| Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 BS Sheena, L Hiebert, H Han, H Ippolito, M Abbasi-Kangevari, ... The lancet Gastroenterology & hepatology 7 (9), 796-829, 2022 | 288 | 2022 |
| Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 F Farzadfar, M Naghavi, SG Sepanlou, SS Moghaddam, WJ Dangel, ... The Lancet 399 (10335), 1625-1645, 2022 | 161 | 2022 |
| Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries SR Knight, CA Shaw, R Pius, TM Drake, L Norman, AO Ademuyiwa, ... The Lancet 397 (10272), 387-397, 2021 | 111 | 2021 |
| Exosomes: Nanoparticulate tools for RNA interference and drug delivery F Shahabipour, N Barati, TP Johnston, G Derosa, P Maffioli, A Sahebkar Journal of cellular physiology 232 (7), 1660-1668, 2017 | 111 | 2017 |
| Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 … AE Micah, IE Cogswell, B Cunningham, S Ezoe, AC Harle, ER Maddison, ... The Lancet 398 (10308), 1317-1343, 2021 | 92 | 2021 |
| Potential therapeutic effects of curcumin in gastric cancer N Barati, AA Momtazi‐Borojeni, M Majeed, A Sahebkar Journal of cellular physiology 234 (3), 2317-2328, 2019 | 68 | 2019 |
| Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model A Razazan, J Behravan, A Arab, N Barati, L Arabi, Z Gholizadeh, ... PloS one 12 (10), e0185099, 2017 | 55 | 2017 |
| A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice A Arab, J Behravan, A Razazan, Z Gholizadeh, AR Nikpoor, N Barati, ... Journal of drug targeting 26 (4), 365-372, 2018 | 46 | 2018 |
| Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential M Teymouri, N Barati, M Pirro, A Sahebkar Journal of cellular physiology 233 (1), 124-140, 2018 | 37 | 2018 |
| Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response A Arab, J Nicastro, R Slavcev, A Razazan, N Barati, AR Nikpoor, ... Immunologic research 66, 200-206, 2018 | 36 | 2018 |
| Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice A Razazan, J Nicastro, R Slavcev, N Barati, A Arab, F Mosaffa, MR Jaafari, ... Scientific reports 9 (1), 2221, 2019 | 33 | 2019 |
| The viral approach to breast cancer immunotherapy A Arab, N Behravan, A Razazn, N Barati, F Mosaffa, J Nicastro, R Slavcev, ... Journal of Cellular Physiology 234 (2), 1257-1267, 2019 | 31 | 2019 |
| Nanoliposomes carrying HER2/neu-derived peptide AE36 with CpG-ODN exhibit therapeutic and prophylactic activities in a mice TUBO model of breast cancer N Barati, AR Nikpoor, A Razazan, F Mosaffa, A Badiee, A Arab, ... Immunology letters 190, 108-117, 2017 | 31 | 2017 |
| P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer N Farzad, N Barati, AA Momtazi-Borojeni, M Yazdani, A Arab, A Razazan, ... Artificial cells, nanomedicine, and biotechnology 47 (1), 664-672, 2019 | 30 | 2019 |
| Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice N Barati, A Razazan, J Nicastro, R Slavcev, A Arab, F Mosaffa, ... Cancer letters 424, 109-116, 2018 | 30 | 2018 |
| Renal hydatid cyst; a rare infectious disease HAM Reza, G Rreza, B Nastaran, MH Mousa Oxford medical case reports 2019 (3), omz011, 2019 | 26 | 2019 |
| Cryptosporidium animal species in Iran: a systematic review and meta-analysis RG Mousa Motavalli Haghi, Zohreh Khorshidvand, Salman Khazaei, Faezeh ... Tropical Medicine and Health 48 (1), 1-15, 2020 | 20 | 2020 |
| Preparation of nanoliposomes linked to HER2/neu‐derived (P5) peptide containing MPL adjuvant as vaccine against breast cancer S Rastakhiz, M Yazdani, S Shariat, A Arab, AA Momtazi‐Borojeni, ... Journal of Cellular Biochemistry 120 (2), 1294-1303, 2019 | 18 | 2019 |
| Development of Solid lipid nanoparticles as Eschar delivery system for Nitrofurazone Using Taguchi Design Approach MHH Behzad Sharif, Nastaran Barati,Fakher rahim International Journal of Research in Pharmaceutical Sciences 1 (4), 466-472, 2010 | 16 | 2010 |
| Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study SR Knight, CA Shaw, R Pius, TM Drake, L Norman, AO Ademuyiwa, ... The Lancet global health 10 (7), e1003-e1011, 2022 | 15 | 2022 |
Mahmoud Reza JaafariProf. of Pharmaceutics and Pharmaceutical NanotechnologyVerified email at mums.ac.ir
